Synthetic sugars are components of novel vaccines against infectious diseases such as multiresistant hospital microbes. A method for synthesizing sugars quickly and reliably was the brainchild of Peter H. Seeberger, Director at the Max Planck Institute of Colloids and Interfaces in Potsdam.